CLINICAL_TRIALS
trial_result
· 2013-09-27
Clinical Trial Update: Oral Aripiprazole Open-Label Rollover Study [Phase 3]
Summary
Open-label rollover Phase 3 trial of oral aripiprazole for schizophrenia has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2013-09-27